Clinical Research Protocols
Scientists from multiple disciples converge at UCI Beckman Laser Institute & Medical Clinic to harness the power of light to develop and test cutting-edge, non-invasive or minimally invasive techniques that are both safe and effective to simultaneously advance basic research and improve the lives of patients. The Institute enrolls more than 250 subjects annually in more than 30 Institutional Review Board (IRB)-approved clinical research protocols.
IRB studies evaluate biophotonic technologies in skin diseases, cancer, cardiovascular disease, diabetes and metabolic disease, trauma and critical care, ophthalmology, neurologic function, head and neck surgery and exercise medicine. Through clinical trials, Institute researchers have pioneered new technologies in cancer photonics and photomedicine for UCI Chao Family Comprehensive Cancer Center, a designated National Cancer Institute (NCI), and UCI Institute for Clinical Translational Science (ICTS), a National Institutes of Health (NIH)-designated Clinical and Translational Science Award (CTSA) program.
Click here to learn more about UCI Health Clinical Research Protocols.
Participation in a clinical research protocol is voluntary. Institute clinicians provide patients with consent forms with information about the treatment(s), expectation(s) and potential risk(s).
During a clinical research protocol, patients can withdraw their consent at any time and clinicians will provide pertinent information that may affect their participation.
Clinical research protocols, informed consent forms and trial progress are reviewed, approved and monitored by the UCI IRB and the clinicians who are conducting the studies. The goal of the IRB is to protect the public, determine whether the possible benefits of participating outweigh the risks and ensure that patients are not pressured to participate.
Click here to learn more.
For more information about clinical research protocols at UCI Beckman Laser Institute & Medical Clinic, please contact Hanna Kim, administrative director, collaborative & clinical research at 949.824.2251 or firstname.lastname@example.org.